Tech Center 1600 • Art Units: 1624
This examiner grants 74% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18117966 | NOVEL HETEROCYCLIC COMPOUNDS | Non-Final OA | Hoffmann-La Roche Inc. |
| 17869755 | NOVEL HETEROCYCLIC COMPOUNDS | Non-Final OA | Hoffmann-La Roche Inc. |
| 17997013 | Small Molecule Inhibitors That Block the Budding of Enveloped Viruses | Non-Final OA | Northwestern University |
| 17552413 | CARBONIC ANHYDRASE INHIBITORS FOR TREATMENT OF NEISSERIA GONORRHOEAE INFECTION | Final Rejection | Purdue Research Foundation |
| 19235393 | MODULATORS OF NLRP3 INFLAMMASOME AND RELATED PRODUCTS AND METHODS | Non-Final OA | Neumora Therapeutics, Inc. |
| 16948467 | TLR7/8 ANTAGONISTS AND USES THEREOF | Non-Final OA | Merck Patent GmbH |
| 18337476 | N-(2-(3-CYANO-2-AZABICYCLO[3.1.0]HEXAN-2-YL)-2-OXOETHYL)QUINOLINE-4-CARBOXAMIDES | Non-Final OA | AstraZeneca AB |
| 18639608 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | Final Rejection | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 18322445 | SMALL MOLECULE DEGRADERS OF THE BROMODOMAIN AND PHD FINGER TRANSCRIPTION FACTOR | Non-Final OA | Regents of the University of Minnesota |
| 18253726 | COMPOUNDS AS PU. 1 INHIBITORS | Non-Final OA | Peking University |
| 17308555 | ARTICLE INCLUDING PHTHALOCYANINE DYES | Final Rejection | VIAVI SOLUTIONS INC. |
| 17638383 | TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND INFLAMMATORY STEATOHEPATITIS WITH SLC25A1 INHIBITORS | Final Rejection | GEORGETOWN UNIVERSITY |
| 17296665 | HALOGENATED ZINC PHTHALOCYANINE PIGMENT AND PRODUCTION METHOD THEREFOR | Non-Final OA | DIC Corporation |
| 18468885 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS | Non-Final OA | Boehringer Ingelheim International GmbH |
| 17016158 | METHOD AND COMPOSITION FOR ADMINISTERING PROSTAGLANDINS | Non-Final OA | MannKind Corporation |
| 17799639 | INHIBITORS OF ULK1/2 AND METHODS OF USING SAME | Final Rejection | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE |
| 18271523 | NOVEL BENZOAZEPINE COMPOUND, AND COMPOSITION AND USE THEREOF | Non-Final OA | SHANGHAITECH UNIVERSITY |
| 18021760 | A PRECIPITATION PROCESS FOR AMORPHOUS LETERMOVIR | Non-Final OA | Lupin Limited |
| 17277829 | STEROL ANALOGS AND USES THEREOF | Final Rejection | ModernaTX, Inc. |
| 18434994 | Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase | Final Rejection | Kadmon Corporation, LLC |
| 18414198 | MORPHIC FORMS OF HEXADECYLOXYPROPYL-PHOSPHONATE ESTERS AND METHODS OF SYNTHESIS THEREOF | Non-Final OA | EMERGENT BIODEFENSE OPERATIONS LANSING LLC |
| 18577856 | NEW SELECTIVE ANGIOTENSIN II COMPOUNDS | Non-Final OA | VICORE PHARMA AB |
| 17793297 | NON-PERIPHERAL QUATERNARY AMMONIUM-MODIFIED ZINC PHTHALOCYANINE AND PREPARATION METHOD AND USE THEREOF | Non-Final OA | FUZHOU UNIVERSITY |
| 17499048 | DIFLUOROMETHYL-AMINOPYRIDINES AND DIFLUOROMETHYL-AMINOPYRIMIDINES | Final Rejection | UNIVERSITÄT BASEL |
| 18230392 | SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG | Final Rejection | Shionogi & Co., Ltd. |
| 17920583 | H4 ANTAGONIST COMPOUNDS | Final Rejection | NXERA PHARMA UK LIMITED |
| 18036549 | KINASE MODULATORS AND METHODS OF USE THEREOF | Non-Final OA | NEURON23, INC. |
| 18461179 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | Final Rejection | Pardes Biosciences, Inc. |
| 17779522 | 1,2,4-TRIAZINE-3,5-DIONE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Final Rejection | SHANGHAI KUNHENG PHARMA-TECH CO., LTD |
| 18334608 | RIP1 Inhibitory Compounds and Methods for Making and Using the Same | Non-Final OA | Rigel Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy